R&D Systems™ Recombinant Human IL-28A/IFN-lambda 2 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Product Code	Brand	Formulation
18196300	R&D Systems™ 1587-IL-025/CF	Lyophilized from a 0.2μm filtered solution in PBS.
18156210	R&D Systems™ 1587-IL-025	Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.

Description

The Recombinant Human IL-28A/IFN-lambda 2 Protein is derived from NS0. The Recombinant Human IL-28A/IFN-lambda 2 Protein has been validated for the following applications: Bioactivity.

Specifications

• Gene ID (Entrez): 282616
• Name: IL-28A/IFN-lambda 2
• Source: Mouse myeloma cell line,NS0-derived human IL-28A/IFN-lambda 2 protein, (N-terminus) Human IL-28A Val26-Val200 Accession &Num; NP_742150 DI 6-His tag (C-terminus)
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• Molecular Weight (g/mol): 20.8 kDa
• Quantity: 25 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Recombinant: Recombinant